World Aquaculture Singapore 2026

June 2-5, 2026

Singapore

BRIDGING THE GAP: UNDERSTANDING SHRIMP IMMUNOLOGY TO ENHANCE AQUACULTURE SUSTAINABILITY

Evelien De Swaef1*, João J. Dantas-Lima1

1IMAQUA,

Ambachtenlaan 27A,

 9080 Lochristi, Belgium

Evelien.Swaef@imaqua.eu



The whiteleg shrimp (Penaeus vannamei) dominates global aquaculture production; however, its continued expansion is increasingly constrained by recurrent disease outbreaks that result in substantial economic losses. A central bottleneck in mitigating these challenges is the incomplete understanding of the functional biology of the shrimp immune system, which limits the development of standardized research tools and evidence-based strategies for immune modulation. Addressing this knowledge gap is therefore critical for advancing disease management and ensuring the sustainability of shrimp farming systems.

Shrimp rely predominantly on innate immunity, a complex and multifaceted defense network that is activated upon recognition of pathogen-associated molecular patterns. Key immune responses include phagocytosis, encapsulation, nodulation, and the production of reactive oxygen species and antimicrobial peptides, all of which contribute to pathogen clearance and the maintenance of physiological homeostasis. In addition to these innate mechanisms, emerging evidence suggests the presence of an adaptive-like immune responses, enabling enhanced protection upon repeated exposure to specific pathogens and potentially representing an evolutionary precursor to vertebrate antibody-mediated immunity.

Despite these advances, shrimp immunology remains relatively undercharacterized. The absence of standardized reference values for baseline immune parameters hampers accurate assessment of shrimp health and immune status under farming conditions. Over the past two decades, significant efforts have been directed toward the development of immunostimulants and other health management strategies. However, progress has been limited by gaps in fundamental knowledge and the lack of robust, validated experimental and diagnostic tools.

This overview underscores the urgent need to further elucidate shrimp immune pathways and to establish standardized benchmarks for immune function. Bridging these gaps will be essential for enabling the development and validation of effective, science-based interventions, ultimately supporting improved disease resilience, productivity, and long-term sustainability in the global shrimp aquaculture industry.